Untreated Adult Acute Myeloid Leukemia Active Not Recruiting Phase 2 Trials for Daunorubicin (DB00694)

IndicationStatusPhase
DBCOND0028532 (Untreated Adult Acute Myeloid Leukemia)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00416598Decitabine as Maintenance Therapy After Standard Therapy in Treating Patients With Previously Untreated Acute Myeloid LeukemiaTreatment
NCT01238211Combination Chemotherapy and Dasatinib in Treating Patients With Newly Diagnosed Acute Myeloid LeukemiaTreatment
NCT01627041Decitabine, Cytarabine, and Daunorubicin Hydrochloride in Treating Patients With Acute Myeloid LeukemiaTreatment
NCT01253070Sorafenib Tosylate and Chemotherapy in Treating Older Patients With Acute Myeloid LeukemiaTreatment
NCT01806571Daunorubicin Hydrochloride, Cytarabine, and Nilotinib in Treating Patients With Newly Diagnosed Acute Myeloid LeukemiaTreatment